Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?
Morgan H. James, Stephen V. Mahler, David E. Moorman, et al.
Current topics in behavioral neurosciences (2016), pp. 247-281
Closed Access | Times Cited: 169

Showing 26-50 of 169 citing articles:

Dynorphin Counteracts Orexin in the Paraventricular Nucleus of the Thalamus: Cellular and Behavioral Evidence
Alessandra Matzeu, Marsida Kallupi, Olivier George, et al.
Neuropsychopharmacology (2017) Vol. 43, Iss. 5, pp. 1010-1020
Open Access | Times Cited: 49
Preliminary examination of the orexin system on relapse-related factors in cocaine use disorder
Robert Suchting, Jin H. Yoon, Guadalupe G. San Miguel, et al.
Brain Research (2019) Vol. 1731, pp. 146359-146359
Closed Access | Times Cited: 45
Sex Differences in Escalated Methamphetamine Self-Administration and Altered Gene Expression Associated With Incubation of Methamphetamine Seeking
Atul P. Daiwile, Subramaniam Jayanthi, Bruce Ladenheim, et al.
The International Journal of Neuropsychopharmacology (2019) Vol. 22, Iss. 11, pp. 710-723
Open Access | Times Cited: 45
The number of lateral hypothalamus orexin/hypocretin neurons contributes to individual differences in cocaine demand
Caroline B. Pantazis, Morgan H. James, Brandon S. Bentzley, et al.
Addiction Biology (2019) Vol. 25, Iss. 4
Open Access | Times Cited: 44
Sleep loss and addiction
Luis Angel López-Muciño, Fabio García‐García, Jonathan Cueto‐Escobedo, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 141, pp. 104832-104832
Closed Access | Times Cited: 26
Future perspectives of emerging novel drug targets and immunotherapies to control drug addiction
Jonaid Ahmad Malik, Javed N. Agrewala
International Immunopharmacology (2023) Vol. 119, pp. 110210-110210
Closed Access | Times Cited: 15
Genetic associations between orexin genes and phenotypes related to behavioral regulation in humans, including substance use
Fazil Alıev, David De Sa Nogueira, Gary Aston‐Jones, et al.
Molecular Psychiatry (2025)
Open Access
Determinants of substance use patterns in patients with narcolepsy type 1: a multi-center comparative cross-sectional study
Laure Peter‐Derex, Emmanuel Fort, Benjamin Putois, et al.
Sleep Medicine (2025) Vol. 129, pp. 148-166
Open Access
Orexin/hypocretin and dysregulated eating: Promotion of foraging behavior
Jessica R. Barson
Brain Research (2018) Vol. 1731, pp. 145915-145915
Open Access | Times Cited: 46
Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil
Aida Mohammadkhani, Morgan H. James, Caroline B. Pantazis, et al.
Brain Research (2019) Vol. 1731, pp. 146461-146461
Open Access | Times Cited: 41
The potential role of the orexin reward system in future treatments for opioid drug abuse
Shahram Zarrabian, Esmail Riahi, Sara Karimi, et al.
Brain Research (2018) Vol. 1731, pp. 146028-146028
Closed Access | Times Cited: 39
Glucagon-like peptide-1 receptor agonist, exendin-4, reduces reinstatement of heroin-seeking behavior in rats
Joaquin E. Douton, Corinne Augusto, Brooke Stoltzfus, et al.
Behavioural Pharmacology (2020) Vol. 32, Iss. 4, pp. 265-277
Open Access | Times Cited: 36
Effect of suvorexant on morphine tolerance and dependence in mice: Role of NMDA, AMPA, ERK and CREB proteins
Peyman Esmaili‐Shahzade‐Ali‐Akbari, Hossein Hosseinzadeh, Soghra Mehri
NeuroToxicology (2021) Vol. 84, pp. 64-72
Closed Access | Times Cited: 31
A balancing act: the role of pro‐ and anti‐stress peptides within the central amygdala in anxiety and alcohol use disorders
Leigh C. Walker
Journal of Neurochemistry (2021) Vol. 157, Iss. 5, pp. 1615-1643
Open Access | Times Cited: 29
The Insomnia-Addiction Positive Feedback Loop: Role of the Orexin System
Jennifer E. Fragale, Morgan H. James, Jorge A. Avila, et al.
Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences (2021), pp. 117-127
Open Access | Times Cited: 29
Orexin (hypocretin) and addiction
Jacqueline B. Mehr, Michelle M. Bilotti, Morgan H. James
Trends in Neurosciences (2021) Vol. 44, Iss. 11, pp. 852-855
Open Access | Times Cited: 29
CART neurons in the lateral hypothalamus communicate with the nucleus accumbens shell via glutamatergic neurons in paraventricular thalamic nucleus to modulate reward behavior
Amit G. Choudhary, Amita R. Somalwar, Sneha Sagarkar, et al.
Brain Structure and Function (2017)
Closed Access | Times Cited: 39
Nucleus Accumbens Shell Orexin-1 Receptors Are Critical Mediators of Binge Intake in Excessive-Drinking Individuals
Kelly Lei, Claudina Kwok, David Darevsky, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 33
Pharmacological and chemogenetic orexin/hypocretin intervention ameliorates Hipp-dependent memory impairment in the A53T mice model of Parkinson’s disease
Miloš Stanojlović, Jean Pierre Pallais, Michael K. Lee, et al.
Molecular Brain (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 30
The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse
Morgan H. James, Jennifer E. Fragale, Shayna L. O’Connor, et al.
Neuropharmacology (2020) Vol. 183, pp. 108359-108359
Open Access | Times Cited: 29
Orexin-1 receptor signaling in ventral tegmental area mediates cue-driven demand for cocaine
Caroline B. Pantazis, Morgan H. James, Shayna L. O’Connor, et al.
Neuropsychopharmacology (2021) Vol. 47, Iss. 3, pp. 741-751
Open Access | Times Cited: 26
Age-specific treatment effects of orexin/hypocretin-receptor antagonism on methamphetamine-seeking behavior
Natalie E. Zlebnik, Nathan A. Holtz, Victoria C. Lepak, et al.
Drug and Alcohol Dependence (2021) Vol. 224, pp. 108719-108719
Open Access | Times Cited: 24
Discovery of Arylsulfonamides as Dual Orexin Receptor Agonists
Dehui� Zhang, David A. Perrey, Ann M. Decker, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 8806-8825
Open Access | Times Cited: 23
New directions in modelling dysregulated reward seeking for food and drugs
Robyn M. Brown, Christopher V. Dayas, Morgan H. James, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 132, pp. 1037-1048
Open Access | Times Cited: 23
Brain regulation of hunger and motivation: The case for integrating homeostatic and hedonic concepts and its implications for obesity and addiction
Ileana Morales
Appetite (2022) Vol. 177, pp. 106146-106146
Open Access | Times Cited: 18

Scroll to top